CHU Rennes, Anesthesia and Intensive Care Department, Rennes, France; Private Hospital, Anesthesia Department, Saint-Grégoire, France; Hypnosis Institute, Émergences Campus, F-35000 Rennes, France.
CHU Rennes, Anesthesia and Intensive Care Department, CIC 1414, Rennes, France.
Br J Anaesth. 2024 Oct;133(4):839-845. doi: 10.1016/j.bja.2024.06.029. Epub 2024 Sep 7.
The way that pain is assessed in the PACU could impact on postoperative pain and analgesic consumption. However, there is currently no evidence to support this speculation. The authors hypothesised that using a comfort scale reduces postoperative opioid consumption when compared with a standard numerical rating scale (NRS) to evaluate pain in the PACU.
In this cluster-randomised trial, patients were assessed using either a comfort scale (comfort group) or a pain NRS (NRS group). The primary outcome was the opioid consumption in the PACU. The main secondary outcomes were postoperative pain, nausea and vomiting, length of stay in the PACU, and satisfaction.
Of 885 randomised patients, 860 were included in the analysis. Opioid consumption in the PACU was comparable in the comfort and NRS groups (median [interquartile range [IQR] 0 (0-5) vs 0 (0-6); P=0.2436), irrespective of the type of surgical procedure. The majority of patients did not need any postoperative opioid (59% in the comfort group and 56% in the NRS group, P=0.2260). There was no difference in postoperative pain, nausea and vomiting, time to reach an Aldrete score ≥9 after extubation, and global satisfaction.
Using a comfort scale to assess pain in the PACU did not spare any opioid compared with use of a standard NRS. Further studies focusing on patients at risk of increased postoperative opioid consumption are necessary.
NCT05234216.
PACU 中疼痛的评估方式可能会影响术后疼痛和镇痛药物的消耗。然而,目前尚无证据支持这种推测。作者假设,与标准数字评分量表(NRS)相比,使用舒适度量表评估 PACU 中的疼痛可以减少术后阿片类药物的消耗。
在这项聚类随机试验中,患者使用舒适度量表(舒适度组)或疼痛 NRS(NRS 组)进行评估。主要结局是 PACU 中的阿片类药物消耗。主要次要结局包括术后疼痛、恶心和呕吐、PACU 停留时间和满意度。
在 885 名随机患者中,860 名患者纳入分析。PACU 中阿片类药物消耗在舒适度组和 NRS 组之间无差异(中位数[四分位距[IQR]0(0-5)与 0(0-6);P=0.2436),与手术类型无关。大多数患者不需要任何术后阿片类药物(舒适度组 59%,NRS 组 56%,P=0.2260)。术后疼痛、恶心和呕吐、拔管后达到 Aldrete 评分≥9 的时间以及总体满意度无差异。
与使用标准 NRS 相比,使用舒适度量表评估 PACU 中的疼痛并不能节省任何阿片类药物。需要进一步研究关注术后阿片类药物消耗增加风险的患者。
NCT05234216。